The Stem Cells products Market is expected to be around US$ 47 Billion by 2028 at a CAGR of 11.77% in the given forecast period.
The stem cell market consists of sales of stem cells products such as human embryonic stem cell, induced adult stem cell and pluripotent stem. Stem cells are the autologous or allogenic cells that can produce into many types of cells in-vitro environment and in in-vivo. Stem cells therapy is planned to aid physician in execution medical treatment of neurodegenerative diseases, heart disease and diabetes. There is a growth in the prevalence of chronic diseases international which drives the stem cell market. Stem-cell therapy is the usage of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most extensively used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use. Extensively used stem cell treatment is the transplantation of blood stem cells to treat diseases and conditions of the blood and immune system, or to restore the blood system after treatments for specific cancers. The factors contribute to the development contain technological advancement in stem cell therapeutics, growing demand for biologics, and a rising focus on the development of personalized medicines. The growing focus on the treatment of neurological disorders contributes to the market expansion.
The global Stem Cells market is segregated on the basis of Product Type as Adult Stem Cell, Human Embryonic Cell, Pluripotent Stem Cell, and Other Product Types. Based on Application the global Stem Cells market is segmented in Neurological Disorders, Orthopaedic Treatments, Oncology Disorders, Injuries and Wounds, Cardiovascular Disorders, and Other Applications. Based on Treatment Type the global Stem Cells market is segmented in Allogeneic Stem Cell Therapy, Autologic Stem Cell Therapy, and Syngeneic Stem Cell Therapy.
The global Stem Cells market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Stem Cells market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
CELGENE CORPORATION, ReNeuron Group plc, Virgin Health Bank , Biovault family, Precious Cells International Ltd, Mesoblast Ltd, Caladrius, Seneca Biopharmaceuticals, Inc., Opexa Therapeutics, Inc., Pluristem Therapeutics Inc, and others are among the major players in the global Stem Cells market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Stem Cells Market has been segmented as below:
Stem Cells Market, By Product Type
Stem Cells Market, By Application
Stem Cells Market, By Treatment Type
Stem Cells Market, By Region
Stem Cells Market, By Company
The report covers:
Report Scope:
The global Stem Cells market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Stem Cells market share. Major industry players with significant revenue share include CELGENE CORPORATION, ReNeuron Group plc, Virgin Health Bank , Biovault family, Precious Cells International Ltd, Mesoblast Ltd, Caladrius, Seneca Biopharmaceuticals, Inc., Opexa Therapeutics, Inc., Pluristem Therapeutics Inc, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Challenges
5. Stem Cells Market, By Product Type
5.1. Key Points
5.2. Adult Stem Cell
5.3. Human Embryonic Cell
5.4. Pluripotent Stem Cell
5.5. Other Product Types
6. Stem Cells Market, By Application
6.1. Key Points
6.2. Neurological Disorders
6.3. Orthopedic Treatments
6.4. Oncology Disorders
6.5. Injuries and Wounds
6.6. Cardiovascular Disorders
6.7. Other Applications
7. Stem Cells Market, By Treatment Type
7.1. Key Points
7.2. Allogeneic Stem Cell Therapy
7.3. Autologic Stem Cell Therapy
7.4. Syngeneic Stem Cell Therapy
8. Competitive Landscape
8.1. Introduction
8.2. Recent Developments
8.2.1. Mergers & Acquisitions
8.2.2. New Product Developments
8.2.3. Portfolio/Production Capacity Expansions
8.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
8.2.5. Others
9. Company Profiles
9.1 CELGENE CORPORATION
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 ReNeuron Group plc
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Virgin Health Bank
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Biovault family
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Precious Cells International Ltd
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Mesoblast Ltd
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Caladrius
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Seneca Biopharmaceuticals, Inc.
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Opexa Therapeutics, Inc.
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Pluristem Therapeutics Inc
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
The Stem Cells Market has been segmented as below:
Stem Cells Market, By Product Type
Stem Cells Market, By Application
Stem Cells Market, By Treatment Type
Stem Cells Market, By Region
Stem Cells Market, By Company
